Expression of leptin receptor in endometrial biopsies of endometrial and ovarian cancer patients

Méndez-López,Luis   Fernando; Dávila-Rodríguez,Martha   Imelda; Zavala-Pompa,Angel; Torres-López,Ernesto; González-Martínez,Blanca   Edelia; López-Cabanillas-Lomelí,Manuel

doi:10.3892/br.2013.125

Expression of leptin receptor in endometrial biopsies of endometrial and ovarian cancer patients

Authors:
- Luis Fernando Méndez-López
- Martha Imelda Dávila-Rodríguez
- Angel Zavala-Pompa
- Ernesto Torres-López
- Blanca Edelia González-Martínez
- Manuel López-Cabanillas-Lomelí
View Affiliations

Affiliations: Faculty of Public Health and Nutrition, Autonomous University of Nuevo León, Monterrey, Nuevo León 64460, Mexico, Division of Genetics, Northeast Biomedical Research Center, Mexican Social Security Institute, Monterrey, Nuevo León 64720, Mexico, Medicina Diagnostica, Monterrey, Nuevo León 64460, Mexico, Department of Immunology, Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, Nuevo León 64460, Mexico
Published online on: May 30, 2013 https://doi.org/10.3892/br.2013.125
Pages: 659-663

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The adipokine leptin plays a critical role in the regulation of reproductive function and there has been growing interest in its potential role in the development of cancers in which obesity is an established risk factor. serum leptin levels were found to be higher in patients diagnosed with endometrial and ovarian cancer compared to those observed in healthy individuals. This study was conducted to determine the expression of the leptin receptor (Ob‑R) in endometrial biopsies of patients diagnosed with endometrial and ovarian cancer. In this preliminary study, immunohistochemistry (IHC) and the color deconvolution method were used to assess the expression levels of the Ob‑R protein in three groups of endometrial tissue: one from patients diagnosed with endometrioid endometrial carcinoma, one from patients diagnosed with ovarian cancer and one from individuals without any diagnosed gynecologic disease (control group). Our results demonstrated that the highest expression of Ob‑R protein in endometrial biopsies was detected in the ovarian cancer group (P=0.000). This finding suggests that changes in Ob‑R expression may be assessed through the measurement of the optical density of endometrial biopsies and may become a useful tool in preventive screening, particularly for ovarian cancer.

View Figures

View References

1	American Cancer Society: Cancer Facts & Figures. 2011, Atlanta: American Cancer Society; 2011
2	Bergstrom A, Pisani P, Tenet V, Wolk A and Adami HO: Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 91:421–430. 2001. View Article : Google Scholar : PubMed/NCBI
3	Calle EE and Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 4:579–591. 2004. View Article : Google Scholar : PubMed/NCBI
4	Farrow DC, Weiss NS, Lyon JL and Daling JR: Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol. 129:1300–1304. 1989.PubMed/NCBI
5	Leitzmann MF, Koebnick C, Danforth KN, et al: Body mass index and risk of ovarian cancer. Cancer. 115:812–822. 2009. View Article : Google Scholar : PubMed/NCBI
6	Levi F, La Vecchia C, Negri E, Parazzini F and Franceschi S: Body mass at different ages and subsequent endometrial cancer risk. Int J Cancer. 50:567–571. 1992. View Article : Google Scholar : PubMed/NCBI
7	Lew EA and Garfinkel L: Variations in mortality by weight among 750,000 men and women. J Chronic Dis. 32:563–576. 1979. View Article : Google Scholar : PubMed/NCBI
8	Lukanova A, Lundin E, Micheli A, et al: Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer. 108:425–432. 2004. View Article : Google Scholar : PubMed/NCBI
9	Risch HA: Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 90:1774–1786. 1998. View Article : Google Scholar : PubMed/NCBI
10	Vona-Davis L and Rose DP: Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer. 14:189–206. 2007. View Article : Google Scholar : PubMed/NCBI
11	Gonzalez RR, Simon C, Caballero-Campo P, et al: Leptin and reproduction. Hum Reprod Update. 6:290–300. 2000. View Article : Google Scholar
12	Greisen S, Ledet T, Moller N, et al: Effects of leptin on basal and FSH stimulated steroidogenesis in human granulosa luteal cells. Acta Obstet Gynecol Scand. 79:931–935. 2000. View Article : Google Scholar : PubMed/NCBI
13	Hamann A and Matthaei S: Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes. 104:293–300. 1996. View Article : Google Scholar : PubMed/NCBI
14	Ashizawa N, Yahata T, Quan J, et al: Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol. 119:65–69. 2010. View Article : Google Scholar : PubMed/NCBI
15	Cymbaluk A, Chudecka-Glaz A and Rzepka-Gorska I: Leptin levels in serum depending on body mass index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol. 136:74–77. 2008. View Article : Google Scholar : PubMed/NCBI
16	Mor G, Visintin I, Lai Y, et al: Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci USA. 102:7677–7682. 2005. View Article : Google Scholar : PubMed/NCBI
17	Gao J, Tian J, Lv Y, et al: Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci. 100:389–395. 2009. View Article : Google Scholar : PubMed/NCBI
18	Uddin S, Bu R, Ahmed M, et al: Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer. Mol Cancer. 8:742009. View Article : Google Scholar : PubMed/NCBI
19	Lang K and Ratke J: Leptin and adiponectin: new players in the field of tumor cell and leukocyte migration. Cell Commun Signal. 7:272009. View Article : Google Scholar : PubMed/NCBI
20	Bjorbaek C, Uotani S, da Silva B and Flier JS: Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem. 272:32686–32695. 1997. View Article : Google Scholar : PubMed/NCBI
21	Bogusiewicz M, Semczuk A, Gogacz M, et al: Lack of correlation between leptin receptor expression and PI3-K/Akt signaling pathway proteins immunostaining in endometrioid-type endometrial carcinomas. Cancer Lett. 238:61–68. 2006. View Article : Google Scholar
22	Yuan SS, Tsai KB, Chung YF, et al: Aberrant expression and possible involvement of the leptin receptor in endometrial cancer. Gynecol Oncol. 92:769–775. 2004. View Article : Google Scholar : PubMed/NCBI
23	Kurman RJ and Shih IeM: The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 34:433–443. 2010. View Article : Google Scholar : PubMed/NCBI
24	Noyes RW, Hertig AT and Rock J: Dating the endometrial biopsy. Am J Obstet Gynecol. 122:262–263. 1975.PubMed/NCBI
25	Silverberg SG, Mutter GL, Kurman RJ, Kubik-Huch RA, Nogales F and Tavassoli FA: Tumors of the uterine corpus: epithelial tumors and related lesions. WHO Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Tavassoli FA and Devilee P: IARC Press; Lyon: pp. 221–232. 2003
26	Ruifrok AC and Johnston DA: Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 23:291–299. 2001.PubMed/NCBI
27	Cornish TC and Haluska MK: Color deconvolution for the analysis of tissue microarrays. Anal Quant Cytol Histol. 31:304–312. 2009.PubMed/NCBI
28	Koda M, Sulkowska M, Wincewicz A, et al: Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann NY Acad Sci. 1095:90–98. 2007. View Article : Google Scholar : PubMed/NCBI
29	Wincewicz A, Koda M, Sulkowska M, Kanczuga-Koda L and Sulkowski S: Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas. Tissue Cell. 40:405–410. 2008. View Article : Google Scholar : PubMed/NCBI
30	Kitawaki J, Koshiba H, Ishihara H, et al: Expression of leptin receptor in human endometrium and fluctuation during the menstrual cycle. J Clin Endocrinol Metab. 85:1946–1950. 2000. View Article : Google Scholar : PubMed/NCBI
31	Johnson CW: Issue in immunohistochemistry. Toxicol Pathol. 27:246–248. 1999. View Article : Google Scholar : PubMed/NCBI
32	Cross SS: Observer accuracy in estimating proportions in images: implications for the semiquantitative assessment of staining reactions and a proposal for a new system. J Clin Pathol. 54:385–390. 2001. View Article : Google Scholar : PubMed/NCBI
33	Diaz LK and Sneige N: Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy. Adv Anat Pathol. 12:10–19. 2005. View Article : Google Scholar : PubMed/NCBI
34	Lehr HA, Jacobs TW, Yaziji H, Schnitt SJ and Gown AM: Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol. 115:814–822. 2001. View Article : Google Scholar : PubMed/NCBI
35	Umemura S, Itoh J, Itoh H, et al: Immunohistochemical evaluation of hormone receptors in breast cancer: which scoring system is suitable for highly sensitive procedures? Appl Immunohistochem Mol Morphol. 12:8–13. 2004. View Article : Google Scholar : PubMed/NCBI